Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs LMWH vs rivaroxaban after tourniquet-free total knee arthroplasty
ChiCTR1800016830Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in venous thromboembolism (VTE) comparing Aspirin, LMWH and Rivaroxaban (3 arms). Primary endpoints: Coagulation parameters, Deep vein thrombosis and 2 more. Started Jun 2018; status: recruiting.
02
Drugs
aspirinlow molecular weight heparin calciumrivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR1800016830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016830.